The gambia president's malaria initiative (PMI)

This $2,580,000 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under its Foreign Assistance for Programs Overseas (CFDA 98.001) program, will deliver quality, high-impact malaria control and prevention services in The Gambia through public and community channels. In line with The Gambia's National Malaria Control Strategy, the 5-year activity (November 2024 to November 2029) aims to contribute to a measurable reduction in malaria mortality and morbidity. The prime awardee, Jhpiego Corp, is a nonprofit global health organization that specializes in health system strengthening, technical assistance, and implementing comprehensive health programs in developing countries.

This activity will deliver quality, high-impact malaria control and prevention services through public and community channels. In line with the gambia's national malaria control strategy, the activity will contribute to a measurable reduction in malaria mortality and morbidity.